SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Orchid Pharma informs about investor presentation

26 May 2026 Evaluate
Pursuant to Regulation 30, Sub- Para 15 of Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended read with SEBI Circular No. SEBI/HO/49/14/14(7)2025- CFD-POD2/I/3762/2026 dated January 30, 2026 and in continuation to our earlier intimation, dated May 19, 2025, regarding the Analysts/Investors Earning Call scheduled to be held on May 26, 2026 at 04:30 PM (IST), Orchid Pharma has enclosed Investors Presentation, including the financial performance and business information of the Company for the Quarter-IV and Financial Year ended March 31, 2026. The Investor Presentation is also made available on the website of the Company at https://www.orchidpharma.com/

The above information is a part of company’s filings submitted to BSE. 

Orchid Pharma Share Price

834.35 -0.05 (-0.01%)
04-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1779.35
Dr. Reddys Lab 1267.05
Cipla 1397.75
Zydus Lifesciences 1085.45
Lupin 2248.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×